• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Development of randomized trials in adults with medulloblastoma-the example of EORTC 1634-BTG/NOA-24

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    34298664.pdf
    Size:
    1.196Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Hau, P.
    Frappaz, D.
    Hovey, E.
    McCabe, Martin G
    Pajtler, K. W.
    Wiestler, B.
    Seidel, C.
    Combs, S. E.
    Dirven, L.
    Klein, M.
    Anazodo, A.
    Hattingen, E.
    Hofer, S.
    Pfister, S. M.
    Zimmer, C.
    Kortmann, R. D.
    Sunyach, M. P.
    Tanguy, R.
    Effeney, R.
    von Deimling, A.
    Sahm, F.
    Rutkowski, S.
    Berghoff, A. S.
    Franceschi, E.
    Pineda, E.
    Beier, D.
    Peeters, E.
    Gorlia, T.
    Vanlancker, M.
    Bromberg, J. E. C.
    Gautier, J.
    Ziegler, D. S.
    Preusser, M.
    Wick, W
    Weller, M.
    Show allShow less
    Affiliation
    Wilhelm Sander-NeuroOncology Unit, Regensburg University Hospital, 93053 Regensburg, Germany.
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Medulloblastoma is a rare brain malignancy. Patients after puberty are rare and bear an intermediate prognosis. Standard treatment consists of maximal resection plus radio-chemotherapy. Treatment toxicity is high and produces disabling long-term side effects. The sonic hedgehog (SHH) subgroup is highly overrepresented in the post-pubertal and adult population and can be targeted by smoothened (SMO) inhibitors. No practice-changing prospective randomized data have been generated in adults. The EORTC 1634-BTG/NOA-23 trial will randomize patients between standard-dose vs. reduced-dosed craniospinal radiotherapy and SHH-subgroup patients between the SMO inhibitor sonidegib (OdomzoTM, Sun Pharmaceuticals Industries, Inc., New York, USA) in addition to standard radio-chemotherapy vs. standard radio-chemotherapy alone to improve outcomes in view of decreased radiotherapy-related toxicity and increased efficacy. We will further investigate tumor tissue, blood, and cerebrospinal fluid as well as magnetic resonance imaging and radiotherapy plans to generate information that helps to further improve treatment outcomes. Given that treatment side effects typically occur late, long-term follow-up will monitor classic side effects of therapy, but also health-related quality of life, cognition, social and professional outcome, and reproduction and fertility. In summary, we will generate unprecedented data that will be translated into treatment changes in post-pubertal patients with medulloblastoma and will help to design future clinical trials.
    Citation
    Hau P, Frappaz D, Hovey E, McCabe MG, Pajtler KW, Wiestler B, et al. Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23. Cancers. 2021 Jul 9;13(14):3451.
    Journal
    Cancers
    URI
    http://hdl.handle.net/10541/624498
    DOI
    10.3390/cancers13143451
    PubMed ID
    34298664
    Additional Links
    https://dx.doi.org/10.3390/cancers13143451
    Type
    Other
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.3390/cancers13143451
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research

    entitlement

    Related articles

    • Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    • Authors: Li Y, Song Q, Day BW
    • Issue date: 2019 Jul 30
    • Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).
    • Authors: Beier D, Proescholdt M, Reinert C, Pietsch T, Jones DTW, Pfister SM, Hattingen E, Seidel C, Dirven L, Luerding R, Reijneveld J, Warmuth-Metz M, Bonsanto M, Bremer M, Combs SE, Rieken S, Herrlinger U, Kuntze H, Mayer-Steinacker R, Moskopp D, Schneider T, Beringer A, Schlegel U, Stummer W, Welker H, Weyerbrock A, Paulsen F, Rutkowski S, Weller M, Wick W, Kortmann RD, Bogdahn U, Hau P
    • Issue date: 2018 Feb 19
    • The Alliance AMBUSH Trial: Rationale and Design.
    • Authors: Mahajan A, Shih H, Penas-Prado M, Ligon K, Aldape K, Hu LS, Loughan AR, Basso MR, Leeper HE, Nahed BV, Stott SL, Geyer S, Giannini C, Galanis E
    • Issue date: 2022 Jan 14
    • Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
    • Authors: Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA
    • Issue date: 2018 Jun
    • Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    • Authors: Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC
    • Issue date: 2018 Dec
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.